OCALA, Fla., Aug. 20, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (AIM) (NYSE American: AIM) (“AIM”) today announced the official print publication of the data analysis from a long-term Early Access ...
Share on Pinterest The novel AI-ready database could help to accelerate cancer immunotherapy research. Image credit: Assembly/Getty Images The Cancer Research Institute (CRI) launches a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results